Enzo Biochem Stock - analyst focus and sector backdrop
19.06.2026 - 16:49:32 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 16:48 CET. Details in the imprint.
Enzo Biochem (US29358P1012) sits in a quieter corner of the US healthcare market today. With no fresh company-specific releases from the lab and diagnostics group, investors are looking instead at how the stock aligns with moves across small-cap life sciences peers this week.
Background and price data on Enzo Biochem stock
Key figures, historical news, and regulatory filings provide context for how Enzo Biochem stock trades within the US diagnostics sector.
What Reuters and filings show
Enzo Biochem’s most recent major corporate step was the sale of its clinical laboratory business to Labcorp, which closed in July 2023 for up to $146 million, including contingent consideration, according to an SEC Form 10-K filing.
The transaction shifted Enzo Biochem’s profile toward life sciences tools, reagents, and intellectual property rather than operating a full-service clinical lab network.
Weekly view and sector comparison
On a weekly basis, trading in many US small-cap healthcare and diagnostics names has been muted, even as broader US indices such as the Standard & Poor's 500 index and the Nasdaq posted gains in recent sessions, as reported by MarketWatch market coverage.
Against this backdrop, Enzo Biochem stock remains a niche play compared with larger listed diagnostics and lab services companies, where liquidity, analyst coverage, and index inclusion tend to be higher.
How the company makes money
Enzo Biochem today focuses on supplying research-use and diagnostic reagents, assay kits, and related technologies, as well as monetizing its intellectual property portfolio in molecular diagnostics and genomics tools.
Where the stock trades today
The shares of Enzo Biochem (US29358P1012) trade on the New York Stock Exchange at $0.85 as of 06/19/2026, 16:30 ET.
Key facts on Enzo Biochem stock
- Company: Enzo Biochem Inc.
- ISIN: US29358P1012
- WKN: 931891
- Ticker: ENZ
- Venue: NYSE
- Price (as of 06/19/2026, 16:30 ET): 0.85 USD
- Market cap: 52,000,000 USD (as of 06/19/2026)
- Sector / Industry: Health Care - Life Sciences Tools & Services
- Index membership: not a member of major headline indices such as the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
